As of Feb 16
| +0.23 / +0.27%|
The 27 analysts offering 12-month price forecasts for Novartis AG have a median target of 95.16, with a high estimate of 103.59 and a low estimate of 75.99. The median estimate represents a +9.49% increase from the last price of 86.91.
The current consensus among 29 polled investment analysts is to Hold stock in Novartis AG. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.